We are live on
!
Find out more
PCM
Patient Capital Management Portfolio holdings
AUM
$2.74B
1-Year Est. Return
43.59%
This Fund
S&P 500
This Quarter
Est. Return
+16.82%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
+$184M
(+11%)
Cap. Flow
-$58.4M
Cap. Flow
% of AUM
-3.09%
Top 10 Holdings %
Top 10 Hldgs %
48.06%
Holding
47
New
5
Increased
10
Reduced
23
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crocs
CROX
|
+$39M |
| 2 |
Royalty Pharma
RPRX
|
+$34.5M |
| 3 |
Illumina
ILMN
|
+$28.5M |
| 4 |
Seadrill
SDRL
|
+$28.1M |
| 5 |
Peloton Interactive
PTON
|
+$8.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$42.4M |
| 2 |
Ovintiv
OVV
|
+$34.8M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$32M |
| 4 |
DXC Technology
DXC
|
+$25M |
| 5 |
Coinbase
COIN
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.19% |
| 2 | Financials | 25.41% |
| 3 | Communication Services | 11.77% |
| 4 | Energy | 9.22% |
| 5 | Healthcare | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Uber
UBER
$153B
| $35.8M | 1.9% |
581,733
-331,684
| -36% | -$17.4M |
|
|
27
Royalty Pharma
RPRX
$25.3B
| $35.2M | 1.87% |
+1,254,780
| New | +$34.5M |
|
|
FISV
28
Fiserv Inc
FISV
$27.5B
| $34.1M | 1.81% |
256,679
-13,947
| -5% | -$1.71M |
|
|
29
Illumina
ILMN
$28.7B
| $33.5M | 1.78% |
+247,417
| New | +$28.5M |
|
|
30
Seadrill
SDRL
$2.73B
| $31.3M | 1.66% |
+662,574
| New | +$28.1M |
|
31
Western Alliance Bancorporation
WAL
$8.91B
| $30.1M | 1.59% |
456,883
-1,472
| -0.3% | -$74.3K |
|
32
Precigen
PGEN
$2.54B
| $21.4M | 1.13% |
15,983,700
+2,230,524
| +16% | +$2.62M |
|
|
EXE
33
Expand Energy Corp
EXE
$21.7B
| $21.1M | 1.12% |
273,711
-45,034
| -14% | -$3.7M |
|
34
Cleveland-Cliffs
CLF
$6.99B
| $21M | 1.11% |
1,027,036
-254,658
| -20% | -$4.36M |
|
35
Rocket Companies
RKT
$37.9B
| $5.16M | 0.27% |
356,677
-40,000
| -10% | -$383K |
|
|
KRTX
36
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.68M | 0.2% |
11,631
-164,621
| -93% | -$32M |
|
37
Lennar Class B
LEN.B
$20.5B
| $1.68M | 0.09% |
13,150
| – | – |
|
38
Diamondback Energy
FANG
$52.8B
| $1.55M | 0.08% |
10,000
| – | – |
|
39
Vontier
VNT
$4.96B
| $1.38M | 0.07% |
40,000
| – | – |
|
40
Teva Pharmaceuticals
TEVA
$40.9B
| $1.04M | 0.06% |
100,000
-25,000
| -20% | -$233K |
|
41
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $994K | 0.05% |
+2,091
| New | +$931K |
|
42
Brilliant Earth
BRLT
$20.5M
| $930K | 0.05% |
250,000
| – | – |
|
|
43
DXC Technology
DXC
$1.74B
| – | – |
-1,198,173
| Closed | -$25M |
|
|
44
Ovintiv
OVV
$16.6B
| – | – |
-730,990
| Closed | -$34.8M |
|
|
SPLK
45
DELISTED
Splunk Inc
SPLK
| – | – |
-290,196
| Closed | -$42.4M |
|
Similar funds
CIAS
LMIM
GC
CC
PA
XL
SFFS
HRCM
Patient Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Patient Capital Management held 47 positions worth $1.89B, up 11% from $1.7B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Patient Capital Management withdrew a net $58.4M in Q4 2023, closing 4 positions and reducing 23 holdings. Its most notable exit was Splunk Inc, an estimated $42.4M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 32% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Patient Capital Management opened a new position in Crocs worth $39.4M.
- Patient Capital Management's largest Q4 2023 buy was Crocs: 422,010 shares worth $39.4M.
- Patient Capital Management added most to Peloton Interactive in Q4 2023, an estimated $8.23M increase.
- Patient Capital Management's biggest Q4 2023 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $32M.
- Patient Capital Management fully exited Splunk Inc in Q4 2023, selling an estimated $42.4M.
- Patient Capital Management's ten largest holdings make up 48% of its $1.89B portfolio in Q4 2023.
- Patient Capital Management opened 5 new positions and closed 4 in Q4 2023.
- Patient Capital Management's portfolio value rose 11% quarter-over-quarter to $1.89B.
Based on Patient Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.